Treatment strategies for mdrtb and xdrtb companion. Epidemiology of multidrugresistant tuberculosis mdrtb. Patients with mdrtb diagnosedregistered under ntp received support through the project staff, in addition to the routine domiciliary care provided by ntp staff. The programmatic management of multidrugresistant tuberculosis mdrtb is entirely based on a who recommended longterm, 1824 month lasting treatment regimen. Professor bengal college of pharmaceutical sciences and research 2. The following health framework for management of dr tb patients has been proposed. The chuuk tb program implemented treatment of mdr ltbi with an 89% completion rate.
Vietnam is among the top 30 high burden of mdrtb countries. Some forms of tb are also resistant to secondline medications, and are called extensively drugresistant tb. This is particularly the case with mdr tb where inadvertent treatment of active tb with a preventative regimen may result in the progression to even more highly resistant and difficult to treat tb. The number of patients commencing mdr tb treatment increased overall between 2009 and 2012. Who consolidated guidelines on drugresistant tuberculosis treatment. Providing treatment for mdr ltbi can be accomplished in a resourcelimited setting, and contributed to preventing mdr tb disease. Patients may have different concurrent conditions, such as hiv infection or diabetes. In order to diagnose mdrtb, drugresistance testing should be conducted to determine if the tb strain is resistant to any drugs other than rifampicin and isoniazid nathanson et al. The bacteria that cause tuberculosis tb can develop resistance to the antimicrobial drugs used to cure the disease.
Translated versions are available to order as a pdf or printed resource. Managing drugresistant tb is extremely challenging, and national guidelines call for treatment of drugresistant tb to be provided by or in close consultation with experts. Papua new guinea png is a high tb burden country with limited information on the magnitude of the mdr tb problem. The document presents comprehensive algorithms for diagnosis and treatment monitoring of pulmonary tb and mdr tb using rapid molecular techniques recommended by who. The who consolidated guidelines on drugresistant tuberculosis treatment 2019, advise that that capreomycin and kanamycin should not be used in mdr tb. Financing for infrastructure improvements will additionally be made available both new construction and renovations to support infection control for mdrtb and tb in public.
The role of surgery in the treatment of pulmonary tb and. A 911 month regimen with seven antibiotics has shown high success rates among selected mdrtb patients in different settings and is conditionally recommended by the world. We sought to determine the proportion of deaths during mdr tb treatment attrib. Jan 17, 2017 antituberculosis drug resistance is a major public health problem that threatens the progress made in tuberculosis care and control worldwide. Tb and multidrugresistant tb mdrtb through scalingup the appropriate use of whorecommended rapid molecular diagnostic techniques. The bacteria that cause tuberculosis tb can develop resistance to the antimicrobial drugs used to. Treatment of drugresistant tuberculosis american journal of respiratory and critical care medicine, 2019.
Patients with mdr tb will have to take at least 5 different drugs, including a daily injection for 4 months 5 days a week. Epidemiology of multidrugresistant tuberculosis mdrtb in. The treatment of mdr tb requires a long lasting drug exposure, and is also significantly associated with high rates of adverse drug events. Treatment of multidrugresistant tuberculosis mdr tb it is accredited by the south african medical association and the norwegian medical association. This mdr tb online course exists as a free selflearning online tool in allowing physicians worldwide to learn and test their knowledge of mdr tb. Multidrugresistant tuberculosis mdrtb is a major threat to global tb control. The effectiveness of surgery in the management of pulmonary tb particularly mdrtb has not, however, been. Multidrug resistant tb fact sheet western cape government. Guideline treatment of tuberculosi s in adults and children version 2. Multidrugresistant tuberculosis mdr tb is a form of tuberculosis tb infection caused by bacteria that are resistant to treatment with at least two of the most powerful firstline anti tb medications drugs, isoniazid and rifampin. Patients with mdr tb diagnosedregistered under ntp received support through the project staff, in addition to the routine domiciliary care provided by ntp staff. It means 85% of diagnosed cases or only 22% of the estimated incident mdrrrtb cases initiated treatment by the year. Providing treatment for mdr ltbi can be accomplished in a resourcelimited setting, and contributed to preventing mdrtb disease.
A list of references is included in a separate document however the majority of these recommendations are based on expert consensus. Worldwide, there were 650,000 multidrugresistant tuberculosis mdrtb cases in 2010, and in 2008 the world health organization estimated that 150,000 deaths occurred annually due to mdrtb. Tags dadaab, east africa, kenya, mdr tb, somali refugees, tb an ounce of prevention. Emergence of drug resistant tuberculosis tb is a major obstacle in the tb control programme of bangladesh. Extensively drug resistant tb xdr tb is a rare type of mdr tb that is resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of three injectable secondline drugs i. The mdr ltbi regimens were safe and well tolerated, and no tb cases occurred among persons treated for mdr ltbi. This study identifies factors associated with the occurrence of mdrtb in patients who underwent firstline tb treatment in addis ababa city. This substance can then be replaced as advised in the guidelines 20, 33. Mdr tb was more prevalent among the afghan patients. Mdrtb multidrug resistant tuberculosis ndoh national department of health nhls national health laboratory services phc primary health care ppm publicprivate mix. Who treatment guidelines for drug resistant tuberculosis. Treatment correlates of successful outcomes in pulmonary multidrugresistant tuberculosis. We describe demographic characteristics and identify risk factors for poor outcome among patients with mdrtb in ho chi minh city hcmc, the most populous city in vietnam.
Modelling the effect of shortcourse multidrugresistant. Tuberculosis tb is a disease caused by bacteria that are spread from person to person through the air. Improving quality of patient data for treatment of. Background the union in collaboration with national tb programme ntp started the communitybased mdr tb care cbmdrtbc project in 33 townships of upper myanmar to improve treatment initiation and treatment adherence. Which shows improvement in coverage and access to mdr tb treatment. Most infections show no symptoms, in which case it is known as latent tuberculosis. Multidrugresistant tuberculosis, which is rare in germany around 100. There were successive annual increments in new enrolments between 2010 and 2012 in at least 18 countries, and an increase of 50% in 2012 was seen in 15 countries, in comparison with 2011 table 2 and fig. The evaluation of a standard treatment regimen of antituberculosis drugs for patients.
Guidelines for treatment of drugsusceptible tuberculosis and patient. Preextensively drug resistant tuberculosis prexdrtb. Multidrug resistant tuberculosis mdrtb remains a serious public health problem with poor treatment outcomes. Treatment outcomes for multidrugresistant tuberculosis under. Treatment for ltbi in contacts of mdrtb patients, federated states of micronesia, 20092012.
About 10% of latent infections progress to active disease which, if left untreated, kills about half of those affected. Collaborative group for the metaanalysis of individual patient data in mdrtb treatment2017, ahmad n, ahuja sd, et al. This study was carried out to detect preextensively drug resistant tb prexdr tb cases among the multidrug resistant tb mdr tb patients in bangladesh, as the early detection of prexdr tb can guide clinicians in the appropriate modification of mdr tb. As a result, mdrtb has become a major focus for tb research in recent years 1, 2, with 480,000 new mdr. Communitybased mdrtb care project improves treatment. Treatment of extrapulmonary tb and of tb in special situations 95. Over 400,000 new cases of mdrtb occur each year and, although their rates are currently unknown, xdrtb cases have been detected in every country where there is. The burden of drugresistant tuberculosis in papua new. Background the union in collaboration with national tb programme ntp started the communitybased mdrtb care cbmdrtbc project in 33 townships of upper myanmar to improve treatment initiation and treatment adherence. Management of contacts of multidrugresistant tuberculosis. Treatment in developed countries is expensive and involves an individualized regimen based on drug susceptibility data and use of reserve drugs. The sooner proper treatment commences, the sooner mdr tb will be contained in the community. There is a paucity of evidence that assessed studies on the treatment of mdr tb, which focus on the effectiveness of the directly observed. Improving quality of patient data for treatment of multidrug.
There is a paucity of evidence that assessed studies on the treatment of mdrtb, which focus on the effectiveness of the directly. During this time most patients with mdr tb are admitted to hospital so that they can be closely monitored for adherence to treatment and to monitor any side effects. Citc is a project of the university of california, san francisco, funded by the centers for. In order to diagnose mdr tb, drugresistance testing should be conducted to determine if the tb strain is resistant to any drugs other than rifampicin and isoniazid nathanson et al.
This chapter provides guidance on the strategies for the treatment of multidrug and extensively drugresistant tb mxdr tb, with emphasis on regimen design. Amikacin is still within their guidance but this is now downgraded to a group c medication, with bedaquiline now being upgraded to a group a drug, whilst delamanid remains a group c drug. Diagnosis of multidrugresistant tuberculosis and extensively. The content of this guidance is meant for coordinators of mdrrr tb treatment who intend to share their experience in patient care to the benefit of national and global treatment policy following several datasharing principles table 1. Another way to prevent getting mdr tb is to avoid exposure to known mdr tb patients in closed or crowded places such as hospitals. Mdrtb treatment regimens typically have a high pill burden, last 20 months or more and often lead to unsatisfactory outcomes. Mdr tb 20% among previously treated tb cases 50% of all mdr cases are estimated to occur in india and china globally, outcome data for mdr tb is limited. The strengths of this guidance are that it draws from our extensive experience in guideline revisions, ipd collection, and ipdma. Position statement on the continued use of the shorter mdrtb. Why we must strengthen basic tb control to defeat drugresistant tb to many, the idea of living in a world where there is no effective treatment for tuberculosis tb seems unthinkable. Of patients with multidrugresistant tuberculosis mdr tb, 50% complete treatment.
Treatment success rates of multidrugresistant tuberculosis mdrtb is a key issue that cannot be ignored. Papua new guinea png is a high tb burden country with limited information on the magnitude of the mdrtb problem. Mdrtb case management ann raftery, rn, bsn, phn, msc curry international tuberculosis center tb case management and contact investigation intensive march 1922, 2019 12 monitor clinical response to treatment sputum smear and culture ensure baseline sputum specimen for smear, culture and dst were obtained prior to mdr tb treatment start. Tb and multidrugresistant tb mdr tb through scalingup the appropriate use of whorecommended rapid molecular diagnostic techniques. Treatment requires a combination of multiple agents and often needs to be individualized, taking numerous considerations into account 1,2. Rapid and accurate detection of mdrtb is critical for appropriate treatment and controlling of tb. It is accredited by the south african medical association and the norwegian medical association. Tuberculosis tb is an infectious disease usually caused by mycobacterium tuberculosis mtb bacteria. Treatment success rates of multidrugresistant tuberculosis mdr tb is a key issue that cannot be ignored. Multidrugresistant tuberculosis mdrtb is a global problem that many countries are challenged. The standard treatment consists of a combination of isoniazid, rifampicin. Surgery has been applied to improve treatment success rates in mdrtb patients and a combined medical and surgical approach is increasingly being used to treat patients with mxdrtb. A survival guide for clinicians, third edition was created through a collaboration of the curry international tuberculosis center citc and the state of california department of public health, tuberculosis control branch cdph. Multidrugresistant tuberculosis treatment adherence in.
Tuberculosis generally affects the lungs, but can also affect other parts of the body. This study was carried out to detect preextensively drug resistant tb prexdrtb cases among the multidrug resistant tb mdrtb patients in bangladesh, as the early detection of prexdrtb can guide clinicians in the appropriate modification of mdrtb. Preventive therapy for child contacts of multidrugresistant tuberculosis. Sep 27, 2018 the national mdr tb treatment program based on the recommendations from the 2011 update of guidelines for the programmatic management of drugresistant tuberculosis. The scope of the who treatment guidelines for drug. The sooner proper treatment commences, the sooner mdrtb will be contained in the community. Algorithm for laboratory diagnosis and treatmentmonitoring. Pdf management of patients with multidrugresistant tuberculosis. Determinants of multidrugresistant tuberculosis in. The document presents comprehensive algorithms for diagnosis and treatmentmonitoring of pulmonary tb and mdrtb using rapid molecular techniques recommended by. Multidrugresistant tuberculosis mdrtb, defined by resistance to isoniazid and rifampicin, the two frontline antimicrobial drugs used to treat tb, presents substantial barriers to the eradication of global tb due to challenges around diagnosis and successful treatment 1,2,3,4. Highest death rates among mdr tb patients seen in african region 19% extensively drug resistant tb xdr tbmdr tb plus resistance to at least 1 fluoroquinolone and 1 secondline.
The treatment of mono and polydrugresistant tb is addressed in chapter 6. Multidrugresistant tuberculosis mdrtb is a form of tuberculosis tb infection caused by bacteria that are resistant to treatment with at least two of the most powerful firstline antitb medications drugs, isoniazid and rifampin. Treatment of multidrugresistant tuberculosis mdrtb. Mdrrr tb treatment guidelines in the coming years, building on a proven track record 2,2123,3234. Risk factors for poor treatment outcomes of 2266 multidrug. This chapter provides guidance on the strategies for the treatment of multidrug and extensively drugresistant tb mxdrtb, with emphasis on regimen design. During this time most patients with mdr tb are admitted to hospital so that they can be closely monitored for adherence to. The course contains seven modules and covers etiology and pathogenesis of tb, diagnosis and treatment, special situations, patientphysician communication, treatment adherence, and tb infection. Up to date, the mdrtb treatment outcome is not sufficiently understood in ethiopia. Funding available for mdr tb has increased from usd 0. The history of tb and mdr tb treatment confirms strict hospitalization of patients as the accepted strategy, although depending on the geographical, economic and social settings, homebased care provided by trained lay and community health workers could achieve comparable results and, in theory.
Because xdr tb is resistant to the most potent tb drugs, patients are left with treatment options that are much. Multidrugresistant tuberculosis mdr tb is a global problem that many countries are challenged. Tb treatment an overview of tb and standard tb treatment for newly diagnosed patients. Mdr tb patients are required to stay in centralised dr tb hospitals, and b decentralising and deinstitutionalising services. Over 400,000 new cases of mdr tb occur each year and, although their rates are currently unknown, xdr tb cases have been detected in every country where there is. Ethiopia is 15th among the 27 mdrtb highburden countries. Who who treatment guidelines for rifampicin and multidrug. Download file the information we have provided here is not exhaustive and is aimed as a practical tool for aid in the management of patients with mdrtb. Patients with drugsusceptible tb must take treatment drugs for 68 months, while mdr tb treatment can take 2 years. Nov 27, 2007 the emergence of multidrugresistant tuberculosis mdr tb and, more recently, extensively drugresistant tb xdr tb is widely considered a serious threat to global tb control. The course contains seven modules and covers etiology and pathogenesis of tb, diagnosis and treatment, special situations. About 600,000 new cases of rifampicinresistant or multidrugresistant tuberculosis mdrrrtb are estimated to emerge each year, requiring treatment with secondline tb treatment regimens. The treatment of multidrug and rifampinresistant tuberculosis mdrrr tb is complex.
Background reliable estimates of the burden of multidrugresistant tuberculosis mdr tb are crucial for effective control and prevention of tuberculosis tb. Most treatment failures for patients with mdr tb are due to death during tb treatment. Pdf pdf icon 37k multidrugresistant tuberculosis mdr tb what is tuberculosis tb. The strategies described in this chapter are largely based on the recommendations from the 2011 update of guidelines for the programmatic management of drug.
Guideline treatment of tuberculosis in adults and children. Current treatment of multidrug resistant tuberculosis in. Health care providers can help prevent mdr tb by quickly diagnosing cases, following recommended treatment guidelines, monitoring patients response to treatment, and making sure therapy is completed. The emergence of multidrugresistant tuberculosis mdrtb and, more recently, extensively drugresistant tb xdrtb is widely considered a serious threat to global tb control.
Mdrtb was more prevalent among the afghan patients. When the diagnosis of ltb is established, there are two options for the management of contacts with exposure to mdr tb. The term active tb drugsafety monitoring and management abbreviated as adsm describes a new tb programme component to provide for the active and systematic clinical and laboratory assessment of patients on treatment for xdr tb, or with new tb drugs or novel mdr tb regimens to detect, manage and report suspected or confirmed drug toxicities. The burden of drugresistant tuberculosis in papua new guinea. However, growing evidence shows that low treatment success rate and high rates of adverse events are associated with this regimen. Contains information and advice about side effects, treatment completion, dot and others sources of support. The document replaces other who recommendations relating to the treatment of multidrug and rifampicinresistant tuberculosis mdrrrtb issued since 2011. The history of tb and mdrtb treatment confirms strict hospitalization of patients as the accepted strategy, although depending on the geographical, economic and social settings, homebased care provided by trained lay and community health workers could achieve comparable results and, in theory. Predictors of poor outcomes vary in different regions.
Who treatment guidelines for drugresistant tuberculosis, 2016 update. Rapid and accurate detection of mdr tb is critical for appropriate treatment and controlling of tb. Also, in 2016 about 19% of previously treated tb cases were estimated to have either rifampicin or multi drug resistant tb. Multidrugresistant tuberculosis mdrtb oxford academic. The global response to mdr tb and xdr tb enrolment on mdr tb treatment blue squares, 20092011. Who treatment guidelines for rifampicin and multidrugresistant tuberculosis, 2018 update guideline development group gdg meeting 16 to 20 july 2018. The demonstrable value of ipd for developing who mdr rr tb treatment guidelines 1,48,49 and continued need for quality ipd to tackle the mdr rr tb epidemic underscore the importance of providing this support. Treatment outcomes for multidrugresistant tuberculosis. It means 85% of diagnosed cases or only 22% of the estimated incident mdr rr tb cases initiated treatment by the year.
1478 1407 296 1541 711 1600 1039 428 1173 226 1081 1304 404 902 1030 345 800 1238 835 77 407 1161 1020 284 759 1541 1504 348 1298 1462 1020 397 605 112 1409 237 876 633 21 1278 310 869 1423 1146 907